|
"wu ch"的相關文件
顯示項目 21-30 / 662 (共67頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2023-11-17 |
USP18 enhances dengue virus replication by regulating mitochondrial DNA release
|
Lai, JH;Wu, DW;Wu, CH;Hung, LF;Huang, CY;Ka, SM;Chen, A;Ho, LJ |
| 國家衛生研究院 |
2023-10-22 |
Potential of thermoresponsive hydrogel as an alternative therapy for rat knee osteoarthritis
|
Kung, Y;Chien, WC;Shen, HH;Chen, SL;Yu, WL;Wang, YC;Chen, WS;Wu, CH |
| 國家衛生研究院 |
2023-09-28 |
Surf4 collaborates with derlin-2 and derlin-1 to mediate cyclooxygenase-2 translocation to the cytosol for degradation
|
Chen, SF;Wu, CH;Lee, YM;Tam, K;Liou, JY;Shyue, SK |
| 國家衛生研究院 |
2023-08-31 |
Dipicolylamine derivatives and their pharmaceutical uses
|
Chen, CT;Shia, KS;Wu, CH;Tsou, LK;Chao, YS |
| 國家衛生研究院 |
2023-08-15 |
Composto e composição farmacêutica
|
Chen, CT;Shia, KS;Wu, CH;Tsou, LK;Chao, YS |
| 國家衛生研究院 |
2023-08-11 |
Cost and effectiveness analyses of the anti-osteoporosis medication in patients with hip fracture in Taiwan: A population-based national claims database analysis
|
Wang, CY;Wu, CH;Chen, HM;Lin, JW;Hsu, CC;Chang, YF;Tai, TW;Fu, SH;Hwang, JS |
| 國家衛生研究院 |
2023-07-21 |
Impact of urbanization on adherence to anti-osteoporosis medications after restrained reimbursement policy in Taiwan
|
Yang, RS;Yang, TH;Fu, SH;Wang, CY;Wu, CH;Hwang, JS |
| 國家衛生研究院 |
2023-07-21 |
Epidemiology of osteoporosis among older long-term care residents: A study using central bone mineral density measurement
|
Fu, SH;Chen, HJ;Hung, CC;Wu, CH;Li, CY;Wang, CY |
| 國家衛生研究院 |
2023-07-21 |
Secular trend of anti-osteoporosis medication initiation in Taiwan between 2008 and 2018: Age matters
|
Yang, TH;Yang, RS;Fu, SH;Wang, CY;Hwang, JS;Wu, CH |
| 國家衛生研究院 |
2023-07-21 |
Whose osteoporosis should be treated among long-term care residents?
|
Fu, SH;Hung, CC;Yang, RS;Wu, CH;Li, CY;Wang, CY |
顯示項目 21-30 / 662 (共67頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
